The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Autophagy and cancer therapy
Open accessAbstract
Although autophagy has been shown to have a clear role as a tumor suppressor mechanism, its role in cancer treatment is still controversial. Because autophagy is a survival pathway activated during nutrient deprivation and other stresses, it is reasonable to think that autophagy can function as a tumor cell survival mechanism activated after cancer treatment. Such a mechanism could be widely important because most cancer treatments induce autophagy in tumor cells. Indeed, many papers have presented data suggesting that tumor cell autophagy induced by anti-cancer treatment inhibits tumor cell killing. However, it has also been proposed that autophagy is a cell death mechanism that could function as a backup when apoptosis is disabled. The fact that there are active clinical trials in patients both using autophagy inhibitors or inducers together with other cancer treatments underscores the importance of understanding and distinguishing between these opposing ideas. Here we discuss some of the recent work studying the role of autophagy with different cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–211 of 211
Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells
Wang, Y., Peng, R.-Q., Li, D., Ding, Y., Wu, X.-Q., Zeng, Y.-X., Zhu, X., & Zhang, X.-S. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10056 · Cited by 66
Altman, B. J., Wofford, J. A., Zhao, Y., Coloff, J. L., Ferguson, E. C., Wieman, H. L., Swearingen, A. E. D. V., Ilkayeva, O., & Rathmell, J. C. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0829 · Cited by 66
Obatoclax and Lapatinib Interact to Induce Toxic Autophagy through NOXA
Tang, Y., Hamed, H. A., Cruickshanks, N. A., Fisher, P. B., Grant, S., & Dent, P. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076851 · Cited by 63
Inhibition of Autophagy Enhances Sunitinib-Induced Cytotoxicity in Rat Pheochromocytoma PC12 cells
Ikeda, T., Ishii, K., Saito, Y., Miura, M., Otagiri, A., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12158fp · Cited by 50
Autophagy: an adaptable modifier of tumourigenesis.
Wilkinson, S., & Ryan, K. (2010) · Current Opinion in Genetics and Development · doi:10.1016/j.gde.2009.12.004 · Cited by 48
Xue, L., Borutaite, V., & Tolkovsky, A. M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01181-4 · Cited by 45
Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling
Bareford, M. D., Hamed, H. A., Allegood, J. C., Cruickshanks, N. A., Poklepovic, A. S., Park, M. A., Öğretmen, B., Spiegel, S., Grant, S., & Dent, P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20562 · Cited by 28
Palacios, C., Martín‐Pérez, R., López-Pérez, A. I., Pandiella, A., & López‐Rivas, A. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.07.002 · Cited by 26
Targeting Chaperone-Mediated Autophagy in Cancer
Thorburn, A. M., & Debnath, J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003390 · Cited by 21
Self-citationKnow thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
Facciabene, A., Santoro, S. P., & Coukos, G. (2012) · OncoImmunology · doi:10.4161/onci.19401 · Cited by 18
Studying autophagy’s relationship to cell death
Thorburn, A. M. (2008) · Autophagy · doi:10.4161/auto.5661 · Cited by 17
Self-citation
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526
Self-citationLoss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., Xu, C., McKenzie, J. A., Zhang, C., Liang, X., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0283 · Cited by 1,539
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Sui, X., Kong, N., Ye, L., Han, W., Zhou, J., Zhang, Q., He, C., & Pan, H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.019 · Cited by 958
Metadata
- Authors
- Maycotte, P., & Thorburn, A.
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2011-01-15
- Volume
- 11
- Issue
- 2
- Pages
- 127-137
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- OpenAlex
- W2128681673
- Cited by
- 393
- References
- 211
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.